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Abstract
Introduction: Most patients referred for lung biopsy have a focal lesion that is likely to be a
carcinoma and fine needle aspiration (FNA) is usually sufficient to confirm diagnosis. Percutaneous
cutting needle biopsy (CNB) is an important and potential diagnostic technique when non
carcinomatous disease is suspected or when the pulmonary disease is unclear, so tissue architecture
is very important.
Case presentation: We present a case of a 24 year old male arrived at our hospital with dyspnea
and unusual computed tomography (CT) findings of sarcoidosis. Chest X-ray and CT scan revealed
multiple masses in both lungs suggesting lung metastasis. Bronchoscopy and bronchoalveolar lavage
did not reveal any malignant cells. None of the laboratory examinations revealed any primary
extrapulmonary tumor. The patient underwent CT-guided core needle biopsy. Histopathological
examination confirmed the diagnosis of sarcoidosis.
Conclusion: CT-guided core needle biopsy is a very helpful diagnostic tool in order to determine
the benign or malignant nature of a thoracic lesion.
Introduction
FNA of focal pulmonary opacities is an accepted technique
for the diagnosis of carcinoma, with a reported sensitivity
greater than 90% [1-2].
Innon-carcinomatousmasses,itssensitivityis22-48%[1-4].
Complication rates are of 29-45% [3].
However it is much less successful in the diagnosis of
benign focal lesions, diffuse lung disease (DLD), or when
the pulmonary disease is unclear, in which case tissue
architecture is important [2-5].
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histological evaluation, although the American Thoracic
Society Guidelines have stated that CNB should not be
used in the diagnosis of DLD [6].
However it is an increasing safe procedure in the
determination of malignant and non-malignant lesions.
The alternatives to percutaneous biopsy include open
biopsy, video-assisted thoracoscopic biopsy and trans-
bronchial biopsy. All of these however require general
anesthesia.
Case presentation
A 24-year old male (of greek origin and nationality)
presented to our hospital complaining dyspnea.
He underwent a chest X-ray that revealed multiple bilateral
pulmonary masses.
The patient underwent a chest CT scan (Siemens,
Somatom Emotion Duo, spiral tomography, 5 mm slice
thickness, mediastinal and pulmonary window), that
revealed well circumscribed multiple round masses,
involving both lungs, suggesting lung metastasis and
enlarged mediastinal lymph nodes (fig. 1, 2).
Further imaging exams were performed (abdominal CT
scan), which excluded any primary extrapulmonary
tumor. The patient underwent other laboratory exams
(blood tests) which had negative results.
The patient therefore underwent a CT-guided core biopsy
using a 18 gauge (G) cutting needle (Somatex, medical
technologies, GmbH, 18 G, 100 mm length).
The method was performed under local anesthesia.
The patient was placed in the appropriate position
considering the location of the lesion.
Using a spiral CT, 5 mm slices were taken in order to
specify the exact skin entry point, for the needle insertion.
The puncture point was prepared in a sterile fashion and
then a 20 G needle was inserted.
A few CT images were taken to ensure that the chosen
point of entry was the appropriate. Then, local anesthetic
(20 cc) 2% lydocaine (xylocaine) was instilled. After that, a
18 G and 10 mm long cutting needle was inserted (fig. 3).
The distance between the skin and the edge of the lesion
was calculated from a relevant CT image. 1-3 specimens
were prelevated from the lesion, which were then put in
formalin for histological examination.
The procedure was successful.
No complications occurred.
Histopathological examination confirmed the diagnosis of
stage II sarcoidosis. It revealed multiple epitelioid cell
granulomas with giant cells, in the absence of micro-
biological or virological abnormalities.
Discussion
The first lung core-needle biopsies were reported by Dutra
and Geraci in 1954 [7] after Silverman introduced the
cutting needle in 1938.
Figure 1. Non contrast chest CT scan, pulmonary window: multiple bilateral masses, in a patchy distribution, of increased
density and lobulated contour. Some have a ground-glass opacity. Associated mediastinal lymphadenopathy (bilateral hilar,
subcarinal, paratracheal) is noted, which is better appreciated using this window.
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diagnosis of focal malignant [7-8], focal benign [8] and
diffuse pulmonary disease [9].
However, series of reported fatalities during the 70’s
mainly due to hemorrhage and pneumothorax rates,
compared to FNA, cast it into disfavor [10-11].
In 1989 the American Thoracic Society Guidelines stated
that CNB remained much less sensitive than open biopsy
in the diagnosis of DLD with a sensitivity of 53-94%.
The automatic cutting needle biopsy devices introduced
over the last few decades, appear to be safer than the older
needles.
Complication rates in recent series are 15-33%.
Mortality rates are 0% [1, 3, 12, 13].
Specificity of the CNB is 100%.
Sarcoidosis is a disease of unknown etiology characterized
by non-necrotizing granulomatous inflammation invol-
ving one or more organs.
Estimates vary, but between 20 to 40% of patients present
asymptomatic bilateral hilar lymphadenopathy [14]. In
the remainder, a variety of tissues may be affected and
mass lesions may result.
Tests formerly believed to be diagnostic of sarcoidosis,
have proven to be non-specific.
These include serum ACE, which can be elevated in a
variety of granulomatous diseases and BAL fluid analysis
[15].
The Kwiem-Stilzbach skin test, although highly specific,
is not standardized and is not widely available.
In patients who present findings uncharacteristic of
sarcoidosis, such as isolated superficial and/or deep
parenchymal nodules or masses and no previous clinical
Figure 3. Chest non-enhancing CT scan, mediastinal
window: the cutting needle was inserted in the chosen
point. Patient was placed in left decubitus position in order
to achieve the right pathway to the chosen lesion to be
biopsied. The tip of the needle is seen inside the lesion.
Figure 2. Non contrast chest CT scan, mediastinal window: multiple, bilateral, heterogeneous masses, with lobulated margins
and mediastinal lymphadenopathy are noted.
Table. Cardinal HRCT Features of Pulmonary Sarcoidosis
Classical features (potentially reversible)
 Intrathoraciclymphadenopathy(hilar,mediastinal,para-aortic,subcarinal)
 Proclivity for upper and mid-lung zones; perihilar (axial) distribution
 Lesions follow bronchovascular bundles, lymphatics
 Nodules (microscopic; macroscopic)
 Consolidation (mass-like lesions; confluent alveolar opacities)
 Ground glass opacities
 Thickened bronchovascular bundles; interlobular septa
 Non septal lines; subpleural linear opacities
Chronic findings (reflect irreversible fibrosis)
 Bronchiectasis; bronchiolectasis
 Cysts; bullae; paracicatricial emphysema
 Anatomic distortion (fissure, bronchi, vessel, displacement)
 Volume loss (particularly upper lobes; hilar retraction)
 Mycetoma (within pre-existing cavity)
 Calcified lymph nodes
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necessary.
Conclusion
Core needle biopsy under CT guidance, is a very helpful,
minimally invasive technique in the determination of
malignant and non malignant lesions, with a few
associated complications.
We showed successfully the usefulness of the method in
the diagnosis of sarcoidosis with unusual CT scan findings.
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